{
  "exclusion_patterns": [
    {
      "pattern": "Relevance to prostate cancer risk assessment and management",
      "keywords": [
        "Family history",
        "Age",
        "Testing challenges",
        "Treatment consequences",
        "Targeted testing"
      ],
      "evidence": "Articles addressing these aspects were excluded as they focused on broader areas rather than prostate cancer screening specifically."
    },
    {
      "pattern": "Supports non-PSA based screening methods",
      "keywords": [
        "DRE",
        "BRCA",
        "Race"
      ],
      "evidence": "Articles advocating for non-PSA methods like digital rectal examinations or genetic testing were excluded as they did not prioritize PSA testing for prostate cancer screening."
    },
    {
      "pattern": "Lack of evidence for prostate cancer screening",
      "keywords": [],
      "evidence": "No articles were found that explicitly denied the effectiveness of prostate cancer screening."
    }
  ],
  "inclusion_patterns": [
    {
      "pattern": "Meets criteria for prostate cancer research",
      "keywords": [
        "PSA screening",
        "Shared decision-making",
        "Randomized controlled trials",
        "Prostate cancer-specific mortality"
      ],
      "evidence": "Articles addressing RCTs, guidelines, and shared decision-making related to prostate cancer screening were included."
    },
    {
      "pattern": "Supports PSA testing for prostate cancer screening",
      "keywords": [
        "PSA testing",
        "Early detection",
        "Prostate cancer"
      ],
      "evidence": "Articles providing evidence for the efficacy of PSA testing in reducing mortality and detecting early-stage prostate cancer were included."
    },
    {
      "pattern": "Relevance to prostate cancer screening",
      "keywords": [
        "PSA screening",
        "Prostate cancer mortality",
        "Harm considerations",
        "Informed decision-making"
      ],
      "evidence": "Articles discussing the benefits and potential harms of prostate cancer screening, alongside patient decision-making considerations, were included."
    }
  ]
}